Datametrex AI Ltd V.DM

New Purchase Order

[Arbourmark]

Toronto, Ontario--(Newsfile Corp. - September 30, 2020) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the "Company" or "Datametrex") is pleased to announce that it received a Purchase Order (the "PO") from a Toronto based film production company, Flatmate Productions Inc., a subsidiary of Cream Production Inc., to provide COVID-19 test kits and related screening solutions. 

"With Toronto based production companies resuming to filming their projects, we feel that film production companies will be an important market for the Company to sell its COVID-19 tests and related services as Toronto is one of the largest film production locations in North America," commented Marshall Gunter CEO of the Company.

In this respect, Ontario is one of the largest production centres in North America, representing approximately 34% of Canadian based film productions. Ontario's film and television industry had a record-breaking year in 2019, with 343 productions bringing in approximately $2.16 billion in production spending for the economy. (Source: Government of Ontario: Record-breaking Year for Ontario's Film and Television Industry)

Datametrex anticipates that it will have little or no upfront costs associated with importing and selling these test kits pursuant to the terms of the PO.

About Cream

Cream is a Toronto and LA based creative production company. They deliver distinctive and top-rated content to television and digital platforms around the world including Netflix, CNN, Hulu, PBS, Discovery Channel, History Channel, and the BBC. Additional information on Cream is available at www.creamproductions.com

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact: 
Marshall Gunter: CEO 
Phone: [phone] 
Email: [e-mail]

 

[Resilience19]

Good to read, especially given that this will form part of the Q3 financials. However, I feel the downside is that several announcements appear piecemeal and lack details (concrete figures, timing etc), especially in the context where we still have little knowledge of margins. This said, I happy to read deals are pilling up up lack of clarity results in a depressed SP compared to what it could

[Petro67]

Hmmm, Looks like my concerns about  the management, expressed couple of weeks ago were right in place. 

[JohnWashier]

Would you care to re-express those concerns for us?

[Petro67]

Nah, I don't want to become public enemy #1 again. It is certain, though that NRs from the management, often lack really important details. 

[Arbourmark]

I have personally spoken to Marshall about news releases not providing enough financial details. He explained that in many cases the customer did not want details listed in news releases. In some cases the customer does not even want their name mentioned. If you recall last week when the released news release about $20m contract with another Film Profuction Company, no name was released. I

[jckhammer]

Anyone who has worked in management or some front office capacity understnad this, but 3/4 of these same posters on here and the other babbling CEO site with so many loudmouths are clueless on this aspect and will continue to nitpick like women at bingo

[Resilience19]

Thanks @Arbourmark. I gather, in that context, that the idea is to take these NRs - or lack thereof (i.e. military contract) - in strides and await quarterlies, while trying to read between the lines if some results and MD&A are short on details.